| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly A Cattaneo, N Cattane, S Galluzzi, S Provasi, N Lopizzo, C Festari, ... Neurobiology of aging 49, 60-68, 2017 | 1159 | 2017 |
| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ... The Lancet Neurology 16 (8), 661-676, 2017 | 659 | 2017 |
| Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol PA Yushkevich, RSC Amaral, JC Augustinack, AR Bender, JD Bernstein, ... Neuroimage 111, 526-541, 2015 | 317 | 2015 |
| Cortex and amygdala morphology in psychopathy M Boccardi, GB Frisoni, RD Hare, E Cavedo, P Najt, M Pievani, ... Psychiatry Research: Neuroimaging 193 (2), 85-92, 2011 | 220 | 2011 |
| The EADC‐ADNI harmonized protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity GB Frisoni, CR Jack Jr, M Bocchetta, C Bauer, KS Frederiksen, Y Liu, ... Alzheimer's & Dementia 11 (2), 111-125, 2015 | 213 | 2015 |
| Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol M Boccardi, R Ganzola, M Bocchetta, M Pievani, A Redolfi, G Bartzokis, ... Journal of Alzheimer's disease 26 (s3), 61-75, 2011 | 176 | 2011 |
| A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals? LEM Wisse, AM Daugherty, RK Olsen, D Berron, VA Carr, CEL Stark, ... Hippocampus 27 (1), 3-11, 2017 | 158 | 2017 |
| Frontotemporal dementia as a neural system disease M Boccardi, F Sabattoli, MP Laakso, C Testa, R Rossi, A Beltramello, ... Neurobiology of aging 26 (1), 37-44, 2005 | 157 | 2005 |
| Delphi definition of the EADC‐ADNI harmonized protocol for hippocampal segmentation on magnetic resonance M Boccardi, M Bocchetta, LG Apostolova, J Barnes, G Bartzokis, ... Alzheimer's & Dementia 11 (2), 126-138, 2015 | 156 | 2015 |
| Training labels for hippocampal segmentation based on the EADC‐ADNI harmonized hippocampal protocol M Boccardi, M Bocchetta, FC Morency, DL Collins, M Nishikawa, ... Alzheimer's & Dementia 11 (2), 175-183, 2015 | 155 | 2015 |
| The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia M Boccardi, MP Laakso, L Bresciani, S Galluzzi, C Geroldi, A Beltramello, ... Neurobiology of aging 24 (1), 95-103, 2003 | 150 | 2003 |
| Abnormal hippocampal shape in offenders with psychopathy M Boccardi, R Ganzola, R Rossi, F Sabattoli, MP Laakso, ... Human brain mapping 31 (3), 438-447, 2010 | 137 | 2010 |
| Alexithymia in healthy women: a brain morphology study G Borsci, M Boccardi, R Rossi, G Rossi, J Perez, M Bonetti, GB Frisoni Journal of Affective Disorders 114 (1-3), 208-215, 2009 | 134 | 2009 |
| Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease C Babiloni, C Del Percio, M Boccardi, R Lizio, S Lopez, F Carducci, ... Neurobiology of aging 36 (2), 556-570, 2015 | 121 | 2015 |
| Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia Z Walker, F Gandolfo, S Orini, V Garibotto, F Agosta, J Arbizu, F Bouwman, ... European journal of nuclear medicine and molecular imaging 45, 1534-1545, 2018 | 114 | 2018 |
| Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study M Boccardi, R Ghidoni, S Govoni, C Testa, L Benussi, M Bonetti, G Binetti, ... Menopause 13 (4), 584-591, 2006 | 113 | 2006 |
| The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers NJ Ashton, A Leuzy, TK Karikari, N Mattsson-Carlgren, A Dodich, ... European journal of nuclear medicine and molecular imaging 48, 2140-2156, 2021 | 112 | 2021 |
| European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission … F Nobili, J Arbizu, F Bouwman, A Drzezga, F Agosta, P Nestor, Z Walker, ... European journal of neurology 25 (10), 1201-1217, 2018 | 110 | 2018 |
| Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia PJ Nestor, D Altomare, C Festari, A Drzezga, J Rivolta, Z Walker, ... European journal of nuclear medicine and molecular imaging 45, 1509-1525, 2018 | 103 | 2018 |
| Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework N Mattsson, A Lönneborg, M Boccardi, K Blennow, O Hansson, ... Neurobiology of aging 52, 196-213, 2017 | 102 | 2017 |
